HEALTH UTILITIES ASSOCIATED WITH HYPOGLYCEMIC EVENTS IN TYPE 2 DIABETES MELLITUS (T2DM) PATIENTS RECEIVING BASAL-BOLUS INSULIN THERAPY

被引：1
|
作者：
Ionova, T. [1 ]
Nikitina, T. [1 ]
Kurbatova, K. [2 ]
机构：
[1] Natl Pirogov Med Surg Ctr, Moscow, Russia
[2] Multinatl Ctr Qual Life Res, St Petersburg, Russia
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.2112
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB73
引用
收藏
页码：A610 / A610
页数：1
相关论文
共 50 条
  • [11] Proportion and characteristics of patients with type 2 diabetes initiating basal insulin therapy with a basal-bolus regimen in China
    Zhang, Puhong
    Zhang, Heng
    Zhu, Dongshan
    Li, Xian
    Ji, Jiachao
    Zhao, Fang
    Lu, Juming
    Jia, Weiping
    Ji, Linong
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34
  • [12] Basal-bolus insulin regimen is effective for hospitalized patients with type 2 diabetes
    不详
    Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 (12): : 791 - 792
  • [13] OPTIMAL REGIMENS OF THE BASAL-BOLUS INSULIN THERAPY IN ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
    Galkina, G. A.
    Voropay, A. A.
    Levkovich, M. A.
    Vorobiov, S. V.
    Komkova, M. V.
    Morozova, N. V.
    BYULLETEN SIBIRSKOY MEDITSINY, 2015, 14 (05): : 15 - U223
  • [14] Characteristics of patients with type 2 diabetes mellitus (T2DM) on basal insulin who do not achieve glycaemic goals
    Brunton, S.
    Blonde, L.
    Chava, P.
    Zhou, R.
    Meyers, J.
    Davis, K.
    Dalal, M.
    DiGenio, A.
    DIABETOLOGIA, 2014, 57 : S54 - S54
  • [15] Treatment Persistence and Switch in German Patients with Type 2 Diabetes Mellitus (T2DM) after Initiating Basal Insulin
    Chou, Engels
    Dippel, Franz-Werner
    Chung, Hsing-Wen
    DIABETES, 2014, 63 : A403 - A403
  • [16] The C-Peptide Index in Korean Type 2 Diabetes Mellitus (T2DM) Patients with Oral Hypoglycemic Agents and Insulin
    Yim, Jung-Eun
    Chon, Suk
    Oh, Seungjoon
    Woo, Jeong-Taek
    Kim, Sung-Woon
    Kim, Jin-Woo
    Kim, Young-Seol
    DIABETES, 2010, 59 : A572 - A572
  • [17] Evaluation of Osmotic Diuresis and Volume Depletion Events in Patients with Type 2 Diabetes Mellitus (T2DM) Receiving Ertugliflozin
    Patel, Shrita M.
    Hickman, Mary A.
    Frederich, Robert
    Lauring, Brett
    Terra, Steven
    Johnson, Susan L.
    Huyck, Susan
    Mancuso, James P.
    DIABETES, 2018, 67
  • [18] HOW HYPOGLYCEMIA IMPACTS QUALITY OF LIFE AND TREATMENT SATISFACTION IN TYPE 2 DIABETES MELLITUS PATIENTS ON BASAL-BOLUS INSULIN THERAPY?
    Ionova, T. I.
    Odin, V., I
    Nikitina, T. P.
    Kurbatova, K. A.
    Shablovskaya, N. E.
    VALUE IN HEALTH, 2013, 16 (07) : A446 - A446
  • [19] Quality Of Life, Hypoglycaemic Symptoms and Treatment Satisfaction in Patients with Type 2 Diabetes Receiving Basal-Bolus Insulin
    Ionova, T. I.
    Odin, V., I
    Nikitina, T. P.
    Kurbatova, K. A.
    DIABETES MELLITUS, 2015, 18 (04): : 48 - 58
  • [20] Continuous Glucose Monitoring in hospitalized Patients with Type 2 Diabetes during Basal-Bolus Insulin Therapy
    Schaupp, Lukas
    Neubauer, Katharina
    Mader, Julia
    Augustin, Thomas
    Spat, Stephan
    Hoell, Bernhard
    Beck, Peter
    Plank, Johannes
    Pieber, Thomas
    WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 : S15 - S15
12345